The Current Ratio as of December 2025 (TTM) for Apimeds Pharmaceuticals US, Inc (APUS) is 12.79

According to Apimeds Pharmaceuticals US, Inc’s latest financial reports and current stock price. The company's current Current Ratio is 12.79. This represents a change of 293.60% compared to the average of 3.25 of the last 4 quarters.

Apimeds Pharmaceuticals US, Inc (APUS) Historical Current Ratio (quarterly & annually)

How has APUS Current Ratio performed in the past?

The mean historical Current Ratio of Apimeds Pharmaceuticals US, Inc over the last ten years is 4.90. The current 12.79 Current Ratio has changed 25.98% with respect to the historical average. Over the past ten years (40 quarters), APUS's Current Ratio was at its highest in in the June 2025 quarter at 12.79. The Current Ratio was at its lowest in in the March 2023 quarter at 0.

Apimeds Pharmaceuticals US, Inc (APUS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Apimeds Pharmaceuticals US, Inc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Apimeds Pharmaceuticals US, Inc (APUS) Average Current Ratio

How has APUS Current Ratio performed in the past?

The current Current Ratio of Apimeds Pharmaceuticals US, Inc (APUS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Apimeds Pharmaceuticals US, Inc (APUS) Current Ratio vs. Peers

How is APUS’s Current Ratio compared to its peers?

Apimeds Pharmaceuticals US, Inc’s Current Ratio is greater than Talphera, Inc. (2.93), greater than MIRA Pharmaceuticals, Inc. (2.79), greater than SCYNEXIS, Inc. (5.20), greater than Milestone Scientific Inc. (1.61), greater than IGC Pharma, Inc. (1.32), greater than Precision Optics Corporation, Inc. (1.29), greater than Q32 Bio Inc. (4.57), less than AN2 Therapeutics, Inc. (31.96), greater than NextCure, Inc. (3.71), greater than Myomo, Inc. (2.39),

Build a custom stock screener for Apimeds Pharmaceuticals US, Inc (APUS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Apimeds Pharmaceuticals US, Inc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Apimeds Pharmaceuticals US, Inc (APUS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Apimeds Pharmaceuticals US, Inc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.